Company attributes
Industry
Location
B2X
CEO
Legal Name
Lucence Diagnostics Pte Ltd.
Legal classification
Date Incorporated
2016
Number of Employees (Ranges)
51 – 2000
Phone Number
+18885823623
Full Address
3520 West Bayshore Road Palo Alto, CA 94303 United States
Founded Date
2016
0Total Funding Amount (USD)
49,200,000
Latest Funding Round Date
November 19, 2019
Competitors
Also Known As
Lucence Diagnostics
Latest Funding Type
Country
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
20,000,000
Public/Private
Private0
Overview
Founded in April 2016 and headquartered in Palo Alto, California, Lucence Diagnostics is a company in the oncology field dedicated to advancing cancer care. Lucence develops non-invasive liquid biopsy tests designed to detect cancer and suggest appropriate treatment. LiquidHALLMARK® is the company's flagship product, operating on Lucence's trademarked, amplicon-based sequencing technology.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
